| Risk and protective factors of non‐alcoholic fatty liver disease in paediatric obesity: A nationwide nested case–control study RR Putri, T Casswall, E Hagman Clinical obesity 12 (2), e12502, 2022 | 15 | 2022 |
| Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity–a nationwide cross-sectional cohort study RR Putri, T Casswall, E Hagman BMC pediatrics 21 (1), 271, 2021 | 15 | 2021 |
| The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study N Prinz, RR Putri, T Reinehr, P Danielsson, D Weghuber, M Norman, ... PLoS Medicine 20 (1), e1004165, 2023 | 12 | 2023 |
| Associations between cardiorespiratory fitness and cardiometabolic risk factors in children and adolescents with obesity L Johansson, RR Putri, P Danielsson, M Hagströmer, C Marcus Scientific reports 13 (1), 7289, 2023 | 7 | 2023 |
| Height and growth velocity in children and adolescents undergoing obesity treatment: a prospective cohort study RR Putri, P Danielsson, C Marcus, E Hagman The Journal of Clinical Endocrinology & Metabolism 109 (1), e314-e320, 2024 | 6 | 2024 |
| Evaluating probiotic efficacy on weight loss in adults with overweight through a double-blind, placebo-controlled randomized trial P Danielsson, RR Putri, C Marcus, E Hagman Scientific Reports 13 (1), 18200, 2023 | 2 | 2023 |
| The liver in pediatric obesity: risks and consequences of increased transaminases and steatotic liver disease R Putri Karolinska Institutet, 2024 | | 2024 |
| Steatotic Liver Disease in Pediatric Obesity and Increased Risk for Youth-Onset Type 2 Diabetes RR Putri, T Casswall, P Danielsson, C Marcus, E Hagman Diabetes Care, dc241236, 2024 | | 2024 |
